Earnings Data
Report Date
Nov 10, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
0.62Last Year’s EPS
1.01Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
GB:0LB2 Q2 2026 Earnings Report
GB:0LB2 Upcoming Earnings
Supernus Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
GB:0LB2 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GB:0LB2 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 03, 2026 | $45.17 | $47.94 | +6.13% |
May 05, 2026 | $49.50 | $52.68 | +6.42% |
Feb 24, 2026 | $52.13 | $56.26 | +7.92% |
Nov 04, 2025 | $56.29 | $47.32 | -15.94% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Supernus Pharmaceuticals (GB:0LB2) report earnings?
Supernus Pharmaceuticals (GB:0LB2) is schdueled to report earning on Nov 10, 2026, After Close (Confirmed).
What is Supernus Pharmaceuticals (GB:0LB2) earnings time?
Supernus Pharmaceuticals (GB:0LB2) earnings time is at Nov 10, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Supernus Pharmaceuticals stock?
The P/E ratio of Supernus Pharmaceuticals is N/A.
What is GB:0LB2 EPS forecast?
GB:0LB2 EPS forecast for the fiscal quarter 2026 (Q3) is 0.62.